Quest diagnostics to highlight strategic priorities to drive sustainable growth and deliver long-term shareholder value at 2025 investor day

Provides long-term outlook beyond 2025: revenues expected to grow at 4-5% compound annual growth rate (cagr); adjusted diluted earnings per share (eps) expected to grow at 7-9% cagr reaffirms guidance for full year 2025 secaucus, n.j. , march 19, 2025 /prnewswire/ -- at a meeting with analysts and investors at its 2025 investor day, members of the leadership team of quest diagnostics (nyse: dgx), a leading provider of diagnostic information services, will discuss the company's strategies to drive sustainable growth and deliver long-term shareholder value.
DGX Ratings Summary
DGX Quant Ranking